Search in
1 service found
Sort by:



Service Description

The company has been developing physiological models for cosmetics and drug candidates screening and now markets Poieskin, the first commercially bioprinted human tissue and collaborates with the world’s leading pharmaceutical and cosmetic groups. Leveraging the NGB platform capabilities and tissue manufacturing the skills developed in the development and production of in vitro tissue models development and production, Poietis has been developing a therapeutic pipeline of several tissue products for wound healing and other applications.


  • SegmentPersonal care

Specialized in

Platform solutions

Sample work


  • Company namePoietis
  • Legal namePoietis S.A.S.
  • HeadquartersPessac, France
  • Number of employees1-100
  • DescriptionPoietis mission is to provide solutions leveraging a proprietary, innovative Next-Generation Bioprinting platform and bring Tissue Engineering therapies to patients. Poietis is a spin-off from INSERM and University of Bordeaux where Laser-Assisted Bioprinting Technology was initially developed.